| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
1,095,971,000 |
| Market
Cap: |
21.93(B) |
| Last
Volume: |
10,341,535 |
Avg
Vol: |
10,496,005 |
| 52
Week Range: |
$12.82 - $22.77 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ-100 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : 4.6 |
| Insider 6 Months : 4.6 |
| Insider 3/6 Months : 9.7 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Teva Pharmaceutical Industries is a pharmaceutical company. Co. operates through three segments: North America, which includes the U.S. and Canada; Europe, which includes the European Union and certain other European countries; and International Markets, which includes all countries in which Co. operates other than those in Co.'s North America and Europe segments. Co.'s products include: AUSTEDO; AJOVY (anti calcitonin gene-related peptide); COPAXONE; BENDEKA and TREANDA; ProAir HFA; ProAir RespiClick; QVAR; QVAR RediHaler; ProAir Digihaler; ArmonAir Digihaler; AirDuo Digihaler; BRALTUS®; CINQAIR/CINQAERO; and AirDuo RespiClick.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
1,113 |
1,113 |
1,113 |
1,113 |
| Total Buy Value |
$20,988 |
$20,988 |
$20,988 |
$20,988 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
1 |
1 |
1 |
1 |
| Total Shares Sold |
58,795 |
458,691 |
1,460,818 |
2,873,120 |
| Total Sell Value |
$891,185 |
$8,046,581 |
$25,902,575 |
$47,429,293 |
| Total People Sold |
2 |
5 |
10 |
14 |
| Total Sell Transactions |
2 |
5 |
27 |
49 |
| End Date |
2025-07-06 |
2025-04-04 |
2024-10-04 |
2023-10-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mcavoy David R. |
EVP, Chief Legal Officer |
• – – |
2025-09-05 |
4 |
B |
$18.86 |
$20,988 |
D/D |
1,113 |
13,027 |
0.01 |
6% |
|
| Hughes Eric A |
See Remarks |
• – – |
2025-08-01 |
4 |
AS |
$15.16 |
$799,437 |
D/D |
(52,742) |
0 |
|
30% |
|
| Hughes Eric A |
See Remarks |
• – – |
2025-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
52,742 |
52,742 |
|
- |
|
| Jover Placid |
See Remarks |
• – – |
2025-08-01 |
4 |
S |
$15.16 |
$91,748 |
D/D |
(6,053) |
6,774 |
|
-30% |
|
| Jover Placid |
See Remarks |
• – – |
2025-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,827 |
12,827 |
|
- |
|
| Kalif Eliyahu Sharon |
EVP, Chief Financial Officer |
• – – |
2025-06-12 |
4 |
AS |
$17.08 |
$952,464 |
D/D |
(55,775) |
403,288 |
|
13% |
|
| Mignone Roberto |
|
– • – |
2025-06-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,632 |
105,315 |
|
- |
|
| Elstein Amir |
|
– • – |
2025-06-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,632 |
2,103,963 |
|
- |
|
| Crane Rosemary A |
|
– • – |
2025-06-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,632 |
113,247 |
|
- |
|
| Zaks Tal Zvi |
|
– • – |
2025-06-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,632 |
58,772 |
|
- |
|
| Vergis Janet S. |
|
– • – |
2025-06-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,632 |
73,697 |
|
- |
|
| Nisen Perry |
|
– • – |
2025-06-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,632 |
105,315 |
|
- |
|
| Shalev Varda |
|
– • – |
2025-06-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,632 |
22,504 |
|
- |
|
| Lieberman Gerald M |
|
– • – |
2025-06-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,632 |
115,657 |
|
- |
|
| Satchi-Fainaro Ronit |
|
– • – |
2025-06-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,632 |
97,909 |
|
- |
|
| Barer Sol J |
|
– • – |
2025-06-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,158 |
426,272 |
|
- |
|
| Shields Matthew |
EVP, Global Operations |
• – – |
2025-06-03 |
4 |
S |
$17.02 |
$105,628 |
D/D |
(6,206) |
9,989 |
|
-16% |
|
| Shields Matthew |
EVP, Global Operations |
• – – |
2025-06-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,195 |
16,195 |
|
- |
|
| Sabag Mark |
See Remarks |
• – – |
2025-05-08 |
4 |
S |
$18.04 |
$6,097,304 |
D/D |
(337,915) |
150,996 |
|
-2% |
|
| Kalif Eliyahu Sharon |
EVP, Chief Financial Officer |
• – – |
2025-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,390 |
459,063 |
|
- |
|
| Sabag Mark |
See Remarks |
• – – |
2025-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,765 |
488,911 |
|
- |
|
| Daniell Richard |
Exec. VP, European Commercial |
• – – |
2025-03-05 |
4 |
AS |
$15.90 |
$1,128,642 |
D/D |
(70,961) |
48,384 |
|
1% |
|
| Daniell Richard |
Exec. VP, European Commercial |
• – – |
2025-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,576 |
119,345 |
|
- |
|
| Weiss Amir |
Chief Accounting Officer |
• – – |
2025-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,566 |
30,250 |
|
- |
|
| Francis Richard D |
President and CEO |
• – – |
2025-03-05 |
4 |
AS |
$15.91 |
$131,427 |
D/D |
(8,259) |
271,783 |
|
1% |
|
602 Records found
|
|
Page 1 of 25 |
|
|
0.04 (0.2%) 
